Forget SpaceX: Is RocketLab Stock the Better Buy?

SpaceX is expected to go public later this year, but reported indications are that its IPO valuation already prices in several years of growth. That implies limited near-term upside for public investors and a high-growth premium baked into comparable private-market valuations. Portfolio implication: the listing could reprice aerospace/space suppliers and attract allocations, but investors should account for elevated execution risk given stretched expectations.

Analysis

SpaceX is expected to go public later this year, but reported indications are that its IPO valuation already prices in several years of growth. That implies limited near-term upside for public investors and a high-growth premium baked into comparable private-market valuations. Portfolio implication: the listing could reprice aerospace/space suppliers and attract allocations, but investors should account for elevated execution risk given stretched expectations.